• Gold Partner

  Chiesi Farmaceutici is among the top 50 pharmaceutical companies in the world. It researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being).
• Silver Partner

  AstraZeneca is a global, science-led, patient-focused pharmaceutical company. It is focused on creating genuinely innovative medicines and improving access to them. Inspired by its Values and what science can do, AstraZeneca is focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.
• Bronze Partners

  	Aguettant is a family-owned pharmaceutical company dedicated to the development, industrial production and distribution of innovative injectable pharmaceutical specialties that meet the demands and the needs of healthcare professionals and patients. Founded in Lyon, France in 1903, Laboratoire Aguettant's growth has been rooted in its engagement with the medical world and its pharmaceutical expertise in injectable medication.
  	GE HealthCare is a leader in prevision care, infusing innovation with patient-focused technologies to enable better care. The company provides medical technologies, digital infrastructure, data analytics, and decision support tools that help healthcare professionals diagnose, treat, and monitor their patients. GE HealthCare's Maternal-Infant Care business mission is "To help send moms and babies home healthy", offering a complete portfolio of perinatal and neonatal equipment and solutions that help clinicians provide exceptional care to women and their new born babies.
  	Gennisium Pharma is a privately owned company, created by individuals with diverse experience in the pharmaceutical industry, and notably, in the development and marketing of treatments for rare metabolism disorders, paediatric formulations and Orphan drugs. It aims to manage key and strategic functions in house, in particular Regulatory Affairs, Medical and Marketing as well as Commercialisation of drugs, with its own sales force, in key European and export countries.
  	Medela turns science into care while nurturing health for generations, through advancing research, observing natural behavior and listening to its customers. Medela supports millions of moms, babies, patients and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela is dedicated to developing innovations that build better outcomes, providing the leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education.
• Our Institutional Partners

  	Krankenhaus Barmherzige Brüder Regensburg is the largest Catholic hospital in Germany and a teaching hospital of the University of Regensburg. Around 3,300 employees in 30 clinics and institutes as well as in 34 centres take care of about 52,000 inpatients and 115,000 outpatients annually. Since 2021, the Barmherzige Brüder Regensburg Hospital has been given the mandate of a maximum care provider.
  	Poznan University of Medical Sciences (PUMS) is a leading Polish medical centre with over 90 years of academic experience and with increasing development. Teaching and research are mainly based on collaboration with 5 Clinical Hospital as well as with other city hospitals, while advanced research at the University is carried out in virtually every field of modern medicine. The research and technological infrastructure of the University is one the most modern in the country and enables the most advanced research works to be effectively supported by the scientific staff. PUMS received the logo HR Excellence in Research, accreditation ACEE and is in the process of implementing GEP.
  	The University of Southampton is a public research university in Southampton, England. The university is known for its strong emphasis on research, innovation, and interdisciplinary study. It offers a broad range of undergraduate and postgraduate programs across various fields, including Engineering, Health Sciences, Humanities, Natural and Environmental Sciences, and Social Sciences. It has a strong international reputation and consistently ranks among the top 100 universities globally.
  	The Hospital Sant Joan de Déu stands as a renowned teaching hospital, specializing in the fields of pediatrics, gynecology, and obstetrics. The institution is equipped with 362 beds and features a suite of 12 state-of-the-art operating rooms. With a dedicated team of over 1,200 professionals, the hospital facilitates more than 4,000 annual births, tends to 130,000 emergency cases, accommodates 26,000 admissions, and conducts 13,000 surgeries, making it a vital healthcare hub in the region.
  	The University Children's Hospital Basel (UKBB) is an independent university competence centre for paediatric and adolescent medicine as well as for teaching and research. As one of the three independent paediatric hospitals in Switzerland, the UKBB plays a central role in ensuring cantonal, regional, and supra-regional paediatric and adolescent medical care. With its leading medical expertise, the UKBB is one of the foremost university paediatric and adolescent medical centres in Switzerland.
  	The Warsaw Medical Academy has consistently upheld a dedicated mission of equipping a highly skilled healthcare workforce to serve the healthcare needs of Poland and the European Union. Its rich legacy of experience, comprehensive academic programs, a predominantly practitioner-oriented faculty, and innovative pedagogical methodologies seamlessly harmonize with the contemporary requirements of employers, invariably contributing to the notable accomplishments of its alumni.

The ESPR is supported by unrestricted grants from our corporate partners. Partner organisations do not influence ESPR policy, content, or programming.

How to partner with the ESPR

Support us in improving newborn and child health.

The ESPR aspires to form strong, mutually-beneficial alliances with its partners towards developing and applying research to improve newborn and child health. We offer a broad range of opportunities to engage and collaborate with our society and support our network of peers and experts in paediatric medical care and innovation. Currently, there are several fields of activity that allow for a tailored partnership:

Contact form: